Very promising news for cancer treatment, and thus should appeal to most of the American population (according to the American Cancer Society's reference information, one out of every two American men and one out of every three American women will have some type of cancer at some point during their lifetime; cancer accounts for 25% of all deaths within the entire country).

A group of graduate students and professors at the University of Calgary made discoveries during the 1990s that something called the reovirus had the ability to kill many types of cancer cells. The nice thing is that the reovirus has almost no other effect on the human body, so the patient doesn't experience the terrible side-effects that are common with treatments like chemotherapy or radiation therapy.

Oncolytics is producing Reolysin, the drug based on the reovirus. More info available from their faq.